A patient undergoing intracranial surgery developed disseminated intravascular coagulation with life threatening peroperative bleeding. Thromboelastography established the diagnosis of hyperfibrinolysis, usually a fatal complication of a neurosurgical operation. With the administration of a high dose regimen of aprotinin (Trasylol®) the haemorrhage was controlled and the hyperfibrinolytic state reversed. Evaluation of blood samples from the jugular bulb suggested that there was a pronounced local release of tissue plasminogen activator into the circulation. (3 Neurol Neurosurg Psychiatry 1995;58:104-106) 
The changes in haemostasis during an operation have been extensively investigated in cardiac bypass surgery' and liver surgery. 2 Although excessive blood loss in neurosurgery may significantly affect morbidity and mortality, very few studies have dealt with changes in haemostasis during intracranial surgery. The brain is a major source of the potent procoagulant tissue factor' and certain types of brain tumour, such as meningioma and glioblastoma, have been found to be rich in tissue plasminogen activator. 4 Preoperatively the concentration of circulating tissue factor was 62 pg/ml. During the operation this-fell to 34-6 pg/ml in arterial blood and to 10-6 pg/ml in jugular blood. The fall continued postoperatively with no detectable circulating tissue factor present by day 5 (table) .
This marker of thrombin generation was raised in arterial blood preoperatively (table) . It rose considerably during the procedure and remained above the normal value at 24 hours. Jugular blood showed consistently lower concentrations.
TISSUE PLASMINOGEN ACTIVATOR
Slightly raised above normal preoperatively, tissue plasminogen activator concentration rose considerably during the procedure, particularly in jugular blood. By 24 hours it had returned to normal.
TOTAL FIBRIN(OGEN) DEGRADATION

PRODUCTS
Total fibrin(ogen) degradation products were raised preoperatively and rose during the operation, falling below preoperative concentrations by 24 hours postoperatively. During the operation the arterial concentration rose above that of jugular blood, but by two hours postoperation the concentrations in jugular and arterial blood were about equal.
Discussion
The data collected from this patient suggest the development of disseminated intravascular coagulation during brain surgery. Major coagulopathy is an infrequent but often catastrophic complication of intracranial pathology. 6 In the patient reported here the presence of plasma tissue factor preoperatively and increase in prothrombin F1 + 2 indicated that activation of coagulation was present before the operation. Disruption of the blood brain barrier and exposure of brain tissue factor to circulating blood might lead to activation of coagulation. During the operation, however, the tissue factor concentrations fell and postoperatively were minimal by day 5. The major component in this patient's coagulopathy was the activation of fibrinolysis. During the procedure, tissue plasminogen activator concentrations in jugular blood were twice those in arterial blood suggesting that tissue plasminogen activator was being released into the circulation by the cerebrovascular endothelium. 
